首页> 外文期刊>Clinical nuclear medicine >FDG-PET imaging in patients with pulmonary carcinoid tumor
【24h】

FDG-PET imaging in patients with pulmonary carcinoid tumor

机译:肺类癌患者的FDG-PET成像

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: This study aimed to assess the imaging findings in patients with pathologically proven carcinoid tumors and determine if SUV can help to differentiate typical from atypical (more aggressive) pulmonary carcinoid tumors. PATIENTS AND METHODS: A retrospective review of patients with a biopsy-proven diagnosis of a pulmonary carcinoid tumor at our institution from 2002 to 2010 that had a preoperative PET scan was performed after institutional review board approval was obtained. PET results, including SUV uptake and location, were recorded as well as all data from pathology reports. Carcinoids were considered to be more aggressive if they showed pathological diagnosis consistent with atypical carcinoid, lymph node invasion, poor histological grade (poorly differentiated), or evidence of systemic metastases. Atypical carcinoid pathology consisted of focal necrosis or a higher mitotic index (2-10 per square millimeter) with features of nests, trabeculae, pleomorphic cells, or dense hyperchromasia. SUV uptake was then evaluated and compared between the typical and atypical carcinoid groups using nonparametric statistical methods. RESULTS: We identified 29 patients from 2002 to 2010 at our institution with a pathological diagnosis of pulmonary carcinoid. Twenty-three were histopathologically typical, and the other 6 showed atypia. Mean (SD) nodule size was 2.4 (1.3) cm in the typical group versus 5.0 (3.2) cm in the atypical group (P = 0.065). Mean (SD) SUV uptake in the typical carcinoid group was 2.7 (1.6) and in the atypical group the SUV was 8.1 (4.1) (P < 0.01). A cutoff SUV of 6 or greater is predictive of malignancy (odds ratio, 23.6; P < 0.01), as well as a nodule size of 3.5 cm or greater (odds ratio, 5.1; P = 0.024). CONCLUSIONS: Preoperative PET imaging result is frequently positive in carcinoid tumors, and the biological behavior correlates well with SUV; however, size is not as strong of a predictor of malignancy. Size of 3.5 cm or greater and SUV of 6 or greater have a predictive value of greater than 95% for malignant histology.
机译:目的:本研究旨在评估经病理证实的类癌肿瘤患者的影像学发现,并确定SUV是否有助于将典型和非典型(更具侵略性)肺类癌区别开来。患者与方法:获得机构审查委员会批准后,对2002年至2010年在我院经活检证实为肺类癌的患者进行了术前PET扫描的回顾性研究。记录PET结果(包括SUV的摄取和位置)以及病理报告中的所有数据。如果类癌表现出与非典型类癌,淋巴结浸润,组织学分级差(分化差)或系统转移的证据一致的病理诊断,则认为它们更具侵略性。非典型类癌病理表现为局灶性坏死或较高的有丝分裂指数(每平方毫米2-10),具有巢,小梁,多形性细胞或致密增生的特征。然后使用非参数统计方法评估并比较了典型和非典型类癌组中的SUV摄取量。结果:我们从2002年至2010年在我们的机构中​​确定了29例经病理诊断为肺类癌的患者。 23例在组织病理学上是典型的,其他6例表现为非典型。典型组的平均(SD)结节大小为2.4(1.3)cm,而非典型组为5.0(3.2)cm(P = 0.065)。典型类癌组的SUV平均摄取(SD)为2.7(1.6),非典型组的SUV为8.1(4.1)(P <0.01)。 SUV截止值为6或更高可预测恶性肿瘤(比值比为23.6; P <0.01)以及结节大小为3.5厘米或更大(比值比为5.1; P = 0.024)。结论:术前PET成像在类癌中通常为阳性,其生物学行为与SUV密切相关。但是,肿瘤大小并不能像恶性肿瘤那样强。对于恶性组织学,3.5厘米或更大的尺寸和6或更大的SUV的预测值大于95%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号